You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Germany Patent: 602007012292


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Germany Patent: 602007012292

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 4, 2028 Lexicon Pharms Inc INPEFA sotagliflozin
⤷  Get Started Free May 29, 2028 Lexicon Pharms Inc INPEFA sotagliflozin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Germany Patent DE602007012292

Last updated: July 28, 2025


Introduction

Germany’s patent DE602007012292, filed under the European Patent Office and granted around 2008, pertains to a novel pharmaceutical invention. A comprehensive understanding of the patent’s scope, claims, and landscape is crucial for stakeholders such as pharmaceutical companies, generic manufacturers, and legal professionals. This analysis provides an in-depth examination, positioning the patent within the broader pharmaceutical innovation ecosystem.


Patent Overview and Filing Context

Patent DE602007012292 was filed by a major pharmaceutical entity, seeking protection over a specific chemical formulation or therapeutic use. The patent’s priority date traces back to 2007, aligning with a period marked by significant innovation in targeted therapies and pharmacokinetic enhancements, especially related to small molecules and biologics. The patent’s strategic scope aims to safeguard novel compounds, formulations, or methods of treatment.


Scope and Claims Analysis

Scope of the Patent

  • Core Focus: The patent predominantly protects a chemical compound, a method of synthesis, or a therapeutic application. It might also encompass derivatives, salts, or polymorphs of a primary active component.
  • Protection Breadth: The scope's breadth hinges on how expansively the claims are drafted—whether they cover a specific compound, a class of compounds, or a set of methods.
    • Narrow claims might cover individual compounds with defined substitution patterns.
    • Broader

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.